Document Detail


Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment.
MedLine Citation:
PMID:  23311977     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Introduction. While the physiological existence of rebound acid hypersecretion (RAHS) after withdrawal of proton pump inhibitors (PPI) therapy is established, the clinical implications are less certain. It has been speculated that a clinical relevant rebound phenomenon may be responsible for difficulties in getting off acid-suppressive medication and partly explain the increase in long-term use of PPI. A number of studies addressing this issue have been published recently. The authors aimed to systematically review the existing evidence of clinically relevant symptoms caused by acid rebound following PPI treatment. Material and methods. PubMed was searched using the terms "rebound acid hypersecretion" and generic names of PPIs. Results. Five studies were included. Two studies on asymptomatic volunteers found that 44% experienced acid-related symptoms up to 4 weeks after treatment was withdrawn. Symptoms were generally mild to moderate and mainly heartburn and regurgitation. Three studies, using patients with reflux disease, found no signs of symptoms caused by acid rebound. Conclusion. Gastric acid rebound hypersecretion following PPI therapy induces reflux-like symptoms post-treatment in asymptomatic volunteers, but the significance of this in patient populations is not clear. The studies in patients with reflux disease found no evidence of symptomatic RAHS, but these studies were hampered by severe methodological weaknesses.
Authors:
Anders Bergh Lødrup; Christina Reimer; Peter Bytzer
Related Documents :
17388297 - Spectroscopic and dft study of tungstic acid peroxocomplexes.
18966237 - Simultaneous reduction of arsenic and lead to hydrides by sodium tetrahydroborate(iii) ...
2600597 - Complexes of zinc, copper, and nickel with the nonprotein amino acid l-alpha-amino-beta...
23701377 - Quantifying coulombic and solvent polarization-mediated forces between dna helices.
16877057 - Are the recommendations on the prevention of neural tube defects working?
8648647 - Control of spot-dependent ppgpp synthesis and degradation in escherichia coli.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-14
Journal Detail:
Title:  Scandinavian journal of gastroenterology     Volume:  -     ISSN:  1502-7708     ISO Abbreviation:  Scand. J. Gastroenterol.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0060105     Medline TA:  Scand J Gastroenterol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Medicine, Køge Hospital, Copenhagen University , Køge , Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of Coumarin and Neoflavone Derivatives as HCV NS5B Polymerase Inhibitors.
Next Document:  ISA-TAB-Nano: a specification for sharing nanomaterial research data in spreadsheet-based format.